Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9470-9478

  Rothmann, Thomas ^a   Hengstermann, Arnd ^a   Whitaker, Noel J ^a   Scheffner, Martin ^a   Zur Hausen, Harald ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; VIRUS PROTEIN;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; VIROGENESIS; VIRUS INFECTION; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0031743945     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9470-9478.1998     Document Type: Article

References (38)

1. Babiss, L. E., and H. S. Ginsberg. 1984. Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. J. Virol. 50:202-212.
2. Babiss, L. E., H. S. Ginsberg, and J. E. Darnell, Jr. 1985. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol. 5:2552-2558.
3. Band, V., and R. Sager. 1989. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA 86:1249-1253.
4. Bantel Schaal, U. 1990. Adeno-associated parvoviruses inhibit growth of cells derived from malignant human tumors. Int. J. Cancer 45:190-194.
5. Barker, D. D., and A. J. Berk. 1987. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156:107-121. (Erratum, 158:263.)
6. Bernards, R., M. G. de Leeuw, A. Houweling, and A. J. van der Eb. 1986. Role of the adenovirus early region 1B tumor antigens in transformation and lytic infection. Virology 150:126-139.
7. Bischoff, J. R., D. H. Kirn, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson Johannes, A. Fattaey, et al. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [see comments]. Science 274:373-376.
8. Dobbelstein, M., J. Roth, W. T. Kimberly, A. J. Levine, and T. Shenk. 1997. Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J. 16:4276-4284.
9. Fallaux, F. J., O. Kranenburg, S. J. Cramer, A. Houweling, H. Van Ormondt, R. C. Hoeben, and A. J. van der Eb. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
10. Funk, W. D., D. T. Pak, R. H. Karas, W. E. Wright, and J. W. Shay. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12:2866-2871.
11. Goodrum, F. D., and D. A. Ornelles. 1997. The early region 1B 55-kDa oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle. J. Virol. 71:548-561.
12. Halbert, D. N., J. R. Cutt, and T. Shenk. 1985. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56:250-257.
13. Heise, C., A. Sampson Johannes, A. Williams, F. McCormick, D. D. Von Hoff, and D. H. Kirn. 1997. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3:639-645.
14. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
15. Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J. C. Biscan, A. Valent, A. Minty, P. Chalon, J. M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
16. Katz, E., and B. J. Carter. 1986. Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene and on tumorigenicity of an NIH 3T3 transformed cell line. Cancer Res. 46:3023-3026.
17. Leppard, K. N., and T. Shenk. 1989. The adenovirus E1B 55-kd protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO J. 8:2329-2336.
18. Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumour suppressor gene. Nature 351:453-456.
19. Logan, J. S., and T. Shenk. 1982. Transcriptional and translational control of adenovirus gene expression. Microbiol. Rev. 46:377-383.
20. Peehl, D. M., and R. G. Ham. 1980. Growth and differentiation of human keratinocytes without a feeder layer or conditioned medium. In Vitro (Rockville) 16:516-525.
21. Pereira, H. G. 1958. A protein factor responsible for early cytopathic effect of adenovirus. Virology 6:601-611.
22. Pilder, S., M. Moore, J. Logan, and T. Shenk. 1986. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell Biol. 6:470-476.
23. Rheinwald, J. G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-343.
24. Ridgway, P. J., A. R. Hall, C. J. Meyers, and A. W. Braithwaite. 1997. p53/E1b 58-kDa complex regulates adenovirus replication. Virology 237:404-413.
25. Roth, J. A., and R. J. Cristiano. 1997. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst. 89:21-39.
26. Rothmann, T., H. A. Katus, R. Hartong, M. Perricaudet, and W. M. Franz. 1996. Heart muscle-specific gene expression using replication defective recombinant adenovirus. Gene Ther. 3:919-926.
27. Sarnow, P., P. Hearing, C. W. Anderson, D. N. Halbert, T. Shenk, and A. J. Levine. 1984. Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J. Virol. 49:692-700.
28. Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387-394.
29. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
30. Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523-5527.
31. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
32. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
33. Shenk, T., N. Jones, W. Colby, and D. Fowlkes. 1980. Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harb. Symp. Quant. Biol. 44(pt.1):367-375.
34. Stampfer, M. R. 1985. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9:107.
35. Valentine, R. C., and H. G. Pereira. 1965. Antigens and structure of the adenovirus. J. Mol. Biol. 13:13-20.
36. Verma, I. M., and N. Somia. 1997. Gene therapy - promises, problems and prospects [news]. Nature 389:239-242.
37. Yew, P. R., and A. J. Berk. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357:82-85.
38. Yew, P. R., X. Liu, and A. J. Berk. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8:190-202.